BioSpace News Archive

On October 9, 2020, Medtainer, Inc. (MDTRD) consummated an exchange agreement with California-based Advanced Container Technologies, Inc. (“ACT”) and its shareholders under which these shareholders exchanged their shares in ACT for 50,000,000 shares of Medtainer’s common stock. As a result, ACT has become the wholly owned subsidiary of

Gift to help bridge worlds of business and science through collaboration across Harvard University Will advance development of life sciences leaders, ground-breaking research

Minnetronix Medical, which partners with companies throughout the world to design, develop and manufacture medical device technology, today announced that it has been awarded a National Institutes of Health (NIH) granti for continued study of its proprietary Neurapheresis™ Cerebrospinal Fluid Treatment Platform

The Ad Council today announced new research findings regarding the current state of loneliness around the world.1

ColdQuanta, the quantum atomics company, today announced “Albert,” its quantum matter system on the cloud. With Albert, users can explore fundamental quantum phenomena such as tunneling and superposition by generating, manipulating, and experimenting with ultracold matter.

Immunomic Therapeutics’ CEO to Present at the 5 th International Virtual Conference on Cancer Research & Development 2020

Renew Biopharma, a leader in drug discovery and development of novel cannabinoids for human therapeutics, announced the addition of Steve Orndorff, Ph.D., as Chief Operating Officer.

ThermoGenesis Holdings, Inc. (Nasdaq: THMO) today announced that it has received notification from the United States Patent and Trademark Office (USPTO) of its intent to issue U.S. Patent No. 10,823,746 on November 3 , for the Company’s new breakthrough lateral flow immunoassay test reader technology, the ThermoGenesis Rea

- Contribution of up to $2.8 million will support clinical advancement of bacTRL-Spike™ oral vaccine candidate - Proprietary bacTRL™ platform can be used to produce vaccines that can be stored at room temperature and administered orally rather than injected

Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(FSE:4PC) (“Perimeter” or the “Company”), is pleased to announce a transition to new roles for two of the Company’s senior leaders with the appointment of Jeremy Sobotta as Chief Executive Officer and Tom Boon as Chief Operating Officer,